These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5527115)

  • 21. [The significance of isoniazid metabolism in genetic studies. Anomalies encountered in trisomy 21 patients].
    Turpin R; Bergogne-Berezin E; Caille B; Salmon-Bonnereau D
    Ann Med Interne (Paris); 1969 Apr; 120(4):243-51. PubMed ID: 5356278
    [No Abstract]   [Full Text] [Related]  

  • 22. [The plasma turnover of 125I beta 2 microglobulin in healthy humans and patients with renal insufficiency (author's transl)].
    Vincent C; Pozet N; Revillard JP
    J Physiol (Paris); 1980; 76(8):885-7. PubMed ID: 6165821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
    Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
    J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The significance of increased lactate concentrations in patients with internal diseases].
    Luft D
    Fortschr Med; 1982 Jan; 100(1-2):34-7. PubMed ID: 7056511
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacometabolic capacity of the liver and the effect of pancreozymin in chronic hepatitis, chronic pancreatitis and diabetes mellitus].
    Geller LI; Griaznova MV; Bulgakova OS; Kozlova ZP
    Ter Arkh; 1982; 54(2):67-9. PubMed ID: 7071776
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of diabetes mellitus on intermediary metabolism].
    Ylikahri R
    Duodecim; 1981; 97(12):806-15. PubMed ID: 7028445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy in renal failure].
    Lachhein L
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 38-40. PubMed ID: 7467564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine metabolism in diabetes.
    Wijekoon EP; Brosnan ME; Brosnan JT
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1175-9. PubMed ID: 17956306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotides in diabetes mellitus and obesity.
    Exton JH
    Adv Cyclic Nucleotide Res; 1980; 12():319-27. PubMed ID: 6250364
    [No Abstract]   [Full Text] [Related]  

  • 31. Branched-chain amino-acid metabolism in renal failure.
    Cano NJ
    J Ren Nutr; 2009 Sep; 19(5 Suppl):S22-4. PubMed ID: 19712871
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug administration in renal insufficiency].
    Mertz DP
    Med Klin; 1980 Aug; 75(16):564-9. PubMed ID: 7412702
    [No Abstract]   [Full Text] [Related]  

  • 33. [Separation of insulinase fractions with polyacrylamide gel electrophoresis].
    Sasivimolkul V; Kallee E; Grimminger H
    Acta Isot (Padova); 1968 Sep; 8(1):41-6. PubMed ID: 5752942
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
    Xu N; Nilsson-Ehle P; Ahrén B
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nifedipine on blood sugar, insulin and glucagon levels after an oral glucose load.
    Ferlito S; Fichera C; Carrà G; Puleo F; Calafato M; Volpicelli D
    Panminerva Med; 1981; 23(2):75-80. PubMed ID: 7033893
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.
    Cohen DM; Jaspan JB; Polonsky KS; Lever EG; Moossa AR
    Gastroenterology; 1984 Sep; 87(3):679-87. PubMed ID: 6146553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
    J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal absorption of 131-I-labeled triolein in various diseases.
    Magas S; Tycowa M; Hasik J
    Pol Med J; 1971; 10(1):36-41. PubMed ID: 5573914
    [No Abstract]   [Full Text] [Related]  

  • 39. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I; Tudurí E; Ripoll C; Nadal A
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucagon].
    Lestradet H
    Cah Coll Med Hop Paris; 1967 Dec; 8(14):1167-73. PubMed ID: 5622181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.